Sector: Healthcare | Industry: Biotechnology & Medical Research |
Company Contact | |
Address: | Suite 1600 - 609 Granville Street Pacific Centre P.O. Box 10068 VANCOUVER BC V7Y 1C3 |
Tel: | N/A |
Website: | https://www.egftheramedhealth.com |
IR: | See website |
Key People | ||
N/A |
Business Overview |
EGF Theramed Health Corp. is a Canada-based consumer technology company engaged in the provision of biomedical online services for monitoring and treating common health problems. The Company, through its subsidiaries, has assets and technologies used in the extraction and purification of botanical extracts and the creation of extract formulations, as well as medical monitoring device technology. The Company is working to collaborate with other companies for medical technology, equipment protocols and laboratory SOPs. The Company is focused on developing products, technologies, and diagnostic tools in personalized medical care areas, including research with natural health and wellness products. The Company is focused on the health care and life sciences sector to develop a personalized health care system. The Company is also exploring opportunities in all medical areas in domestic and international markets. Its portfolio includes Pharmadelic Labs and Green Parrot Labs. |
Financial Overview |
For the six months ended 31 December 2023, EGF Theramed Health Corp revenues was not reported. Net loss decreased 75% to C$102K. Lower net loss reflects Investor communications decrease from C$197K (expense) to C$0K, Professional fees decrease of 92% to C$6K (expense), Gain (loss) on foreign exchange increase from C$23K (expense) to C$1K (income). Basic Earnings per Share excluding Extraordinary Items increased from -C$0.04 to -C$0.01. |
Reporting Currency: | Canadian Dollars |
Enterprise value: | $2.90M as of Dec 31, 2023 |
Annual revenue (TTM): | $0.00M as of Dec 31, 2023 |
EBITDA (TTM): | -$0.29M as of Dec 31, 2023 |
Net annual income (TTM): | -$0.32M as of Dec 31, 2023 |
Free cash flow (TTM): | -$0.17M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $1.37M as of Dec 31, 2023 |
Shares outstanding: | 11,391,161 as of Dec 31, 2023 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |